Fig. 6From: Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cellsLocalization of FUS in prostate cancer cells upon platinum drug treatments. Immunofluorescence staining of FUS and Coilin the localization response to 24 h drug treatments in the nuclei of A LNCaP, B PC-3, and C 22Rv1 cells. FUS (green), Coilin (red), merge of FUS and Coilin (Merge RG), brightfield, DAPI, and Merge of FUS, Coilin and DAPI is shown. Scale bars, 5 µmBack to article page